Effect of oral phytoestrogen on androgenicity and insulin sensitivity in postmenopausal women
Authors:
- 27 December 2011
- journal article
- research article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 14 (4) , 315-319
Abstract
Aim: The aim of this study was to determine and compare the effect of treatment with transdermal oestrogen and phytoestrogen on insulin sensitivity and sex hormone‐binding globulin (SHBG) levels in healthy postmenopausal women. Methods: Forty‐three healthy postmenopausal women aged 68 ± 7 (mean ± SD) years who were not receiving hormonal replacement therapy completed a 3 month randomized drug therapy study. The participants were randomized to one of four groups: 0.05 mg or 0.1 mg transdermal oestrogen/day, or 40 or 80 mg oral phytoestrogen (Promensil)/day insulin sensitivity was indirectly measured using the quantitative insulin sensitivity check index (QUICKI). SHBG, total testosterone, oestradiol, and fasting glucose and insulin levels for calculation of insulin sensitivity were obtained at baseline and at monthly intervals during the 3 months of therapy. Results: In healthy nondiabetic postmenopausal women, the rate of change in QUICKI was significantly different between the red clover based phytoestrogen and transdermal oestrogen groups, so that after three months of therapy, QUICKI with red clover based phytoestrogen therapy was lower than that in the transdermal oestrogen group, p = 0.01. Red clover based phytoestrogen therapy was not associated with any changes in SHBG levels whereas transdermal estrogen therapy significantly increased SHBG levels, p = 0.05. Conclusions: In contrast to transdermal oestrogen therapy, oral phytoestrogen therapy does not decrease androgenicity and is associated with a decrease in insulin sensitivity. These effects are similar to those of raloxifene and consistent with phytoestrogen's selective oestrogen receptor modulator properties.Keywords
This publication has 16 references indexed in Scilit:
- The red clover (Trifolium pratense) isoflavone biochanin A inhibits aromatase activity and expressionBritish Journal of Nutrition, 2008
- Molecular aspects of phytoestrogen selective binding at estrogen receptorsJournal of Pharmaceutical Sciences, 2007
- Clinical studies of red clover (Trifolium pratense) dietary supplements in menopause: a literature reviewMenopause, 2006
- Differential Effects of Raloxifene and Estrogen on Insulin Sensitivity in Postmenopausal WomenJournal of the American Geriatrics Society, 2003
- Effects of supplementation with purified red clover (Trifolium pratense) isoflavones on plasma lipids and insulin resistance in healthy premenopausal womenBritish Journal of Nutrition, 2003
- Beneficial Effects of Soy Phytoestrogen Intake in Postmenopausal Women With Type 2 DiabetesDiabetes Care, 2002
- Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In HumansThe Journal of Clinical Endocrinology & Metabolism, 2000
- Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A site-directed mutagenesis study.Environmental Health Perspectives, 1998
- Effects of low doses of transdermal 17 beta-estradiol on carbohydrate metabolism in postmenopausal womenThe Journal of Clinical Endocrinology & Metabolism, 1992
- Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG)Journal of Steroid Biochemistry, 1987